Literature DB >> 34590414

Extending the clinical phenotype of SPTAN1: From DEE5 to migraine, epilepsy, and subependymal heterotopias without intellectual disability.

Ana Victoria Marco Hernández1,2, Alfonso Caro1, Alejandro Montoya Filardi3, Miguel Tomás Vila2, Sandra Monfort1, Beatriz Beseler Soto2, Juan José Nieto-Barceló2, Francisco Martínez1.   

Abstract

Mutations in SPTAN1 gene, encoding the nonerythrocyte αII-spectrin, are responsible for a severe developmental and epileptic encephalopathy (DEE5) and a wide spectrum of neurodevelopmental disorders, as epilepsy with or without intellectual disability (ID) or ID with cerebellar syndrome. A certain genotype-phenotype correlation has been proposed according to the type and location of the mutation. Herein, we report three novel cases with de novo SPTAN1 mutations, one of them associated to a mild phenotype not previously described. They range from (1) severe developmental encephalopathy with ataxia and a mild cerebellar atrophy, without epilepsy; (2) moderate intellectual disability, severe language delay, ataxia and tremor; (3) normal intelligence, chronic migraine, and generalized tonic-clonic seizures. Remarkably, all these patients showed brain MRI abnormalities, being of special interest the subependymal heterotopias detected in the latter patient. Thus we extend the SPTAN1-related phenotypic spectrum, both in its radiological and clinical involvement. Furthermore, after systematic analysis of all the patients so far reported, we noted an excess of male versus female patients (20:9, p = 0.04), more pronounced among the milder phenotypes. Consequently, some protection factor might be suspected among female carriers, which if confirmed should be considered when establishing the pathogenicity of milder genetic variants in this gene.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ataxia; cerebellar atrophy; intellectual disability; spectrin; subependymal heterotopia

Mesh:

Year:  2021        PMID: 34590414     DOI: 10.1002/ajmg.a.62507

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.

Authors:  Liedewei Van de Vondel; Jonathan De Winter; Danique Beijer; Giulia Coarelli; Melanie Wayand; Robin Palvadeau; Martje G Pauly; Katrin Klein; Maren Rautenberg; Léna Guillot-Noël; Tine Deconinck; Atay Vural; Sibel Ertan; Okan Dogu; Hilmi Uysal; Vesna Brankovic; Rebecca Herzog; Alexis Brice; Alexandra Durr; Stephan Klebe; Friedrich Stock; Almut Turid Bischoff; Tim W Rattay; María-Jesús Sobrido; Giovanna De Michele; Peter De Jonghe; Thomas Klopstock; Katja Lohmann; Ginevra Zanni; Filippo M Santorelli; Vincent Timmerman; Tobias B Haack; Stephan Züchner; Rebecca Schüle; Giovanni Stevanin; Matthis Synofzik; A Nazli Basak; Jonathan Baets
Journal:  Mov Disord       Date:  2022-02-12       Impact factor: 9.698

2.  Longitudinal neurodevelopmental profile of a pediatric patient with de novo SPTAN1, epilepsy, and left hippocampal sclerosis.

Authors:  C Luongo-Zink; C Ammons; R Al-Ramadhani; R Logan; K E Ono; S Bhalla; A Kheder; D J Marcus; D L Drane; D J Bearden
Journal:  Epilepsy Behav Rep       Date:  2022-05-08

3.  Commentary: SPTBN5, encoding the βV-spectrin protein, leads to a syndrome of intellectual disability, developmental delay, and seizures.

Authors:  Liedewei Van De Vondel; Jonathan De Winter; Jonathan Baets
Journal:  Front Mol Neurosci       Date:  2022-09-27       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.